Broccia G, Deplano Wilma, Dessalvi P, Giannico Barbara, Luxi G, Chessa E, Murru Antonietta
Divisione di Ematologia, Ospedale Oncologico A. Businco, Cagliari, Italy.
Hematol Oncol. 2004 Sep;22(3):91-109. doi: 10.1002/hon.733.
We have collected, by an active retrospective survey, all the cases of hematologic malignancies (HM) newly diagnosed during the time period 1974-1993 in the resident population of Sardinia. Diagnosis was deemed valid, after consultation of clinical records, in more than 90% of the 7264 collected cases. The number of newly diagnosed cases by year more than doubled during the 20-year period investigated. This striking increase can be only partially accounted for by ageing of population. Indeed, age-specific and age-adjusted rates of most of HM increased during this period, although Hodgkin Disease (HD), Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL) were notable exceptions. The observed increase in rates is likely, in a large part, to be fictitious, due to easier access to a health care system, which in the meantime, improved its diagnostic efficiency. This was particularly evident for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and some others myelo- and lympho-proliferative disorders, but its relevance declined after 1984-1989. A likely true increase in occurrence was evidenced for Non-Hodgkin Lymphomas (NHL) and similarly, although to a lesser extent and more doubtful, for Myelodysplasias (MDS) and Acute Myeloid Leukemia (AML). At the end of the studied period each type of HM presented age and sex distributions and age-adjusted rates that show only minor differences from those reported for other western countries. No argument emerged to suggest that any genetic peculiarities of the Sardinian population might have affected the occurrence of HM. The confounding effects of improved diagnostic efficiency have prevented a reliable assessment of influence on incidences of environmental and socio-economic changes that, in relatively recent times, have occurred in Sardinia.
通过一项积极的回顾性调查,我们收集了1974年至1993年期间撒丁岛常住人口中新诊断的所有血液系统恶性肿瘤(HM)病例。经查阅临床记录,在收集的7264例病例中,超过90%的诊断被认为有效。在所调查的20年期间,每年新诊断病例数增加了一倍多。这一显著增加仅部分可归因于人口老龄化。事实上,在此期间,大多数血液系统恶性肿瘤的年龄特异性和年龄调整发病率有所上升,不过霍奇金病(HD)、慢性粒细胞白血病(CML)和急性淋巴细胞白血病(ALL)是明显的例外。观察到的发病率上升在很大程度上可能是虚构的,这是由于更容易获得医疗保健系统的服务,与此同时,该系统的诊断效率也有所提高。这在慢性淋巴细胞白血病(CLL)、多发性骨髓瘤(MM)和其他一些骨髓和淋巴细胞增殖性疾病中尤为明显,但在1984 - 1989年之后其相关性有所下降。非霍奇金淋巴瘤(NHL)的发病率可能确实出现了真正的上升,同样,骨髓增生异常综合征(MDS)和急性髓系白血病(AML)的发病率虽上升幅度较小且更具疑问,但也可能出现了真正的上升。在研究期结束时,每种血液系统恶性肿瘤的年龄和性别分布以及年龄调整发病率与其他西方国家报告的情况相比,仅显示出微小差异。没有证据表明撒丁岛人群的任何遗传特性可能影响了血液系统恶性肿瘤的发生。诊断效率提高的混杂效应阻碍了对撒丁岛近期发生的环境和社会经济变化对发病率影响的可靠评估。